Please assess the completion status of the following clinical trial:

Trial Title: Randomized Trial of Alternative HPV Vaccination Schedules in Males in a University Setting

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Males age 18-26~Exclusion Criteria:~* Hospitalization within the past year~* Previous HPV vaccination~  \>/=5 sexual partners (i.e., insertive intercourse) No other drug studies within 30 days of proposed HPV vaccination~* History of genital warts~* Immunosuppression~* Other vaccines within 8 days of proposed HPV vaccination~* Hypersensitivity to yeast or HPV vaccine components~* Known autoimmune disorders~* Receipt of immunoglobulins or blood product within 90 days of enrollment (may defer until 90 days completed)~* Serious Adverse Reaction to HPV vaccine

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 26 Years
- Healthy Volunteers: t

Study Arms:
- 12 months (Type: EXPERIMENTAL): Administration of 3rd dose at 12 months quadrivalent human papillomavirus vaccine
- 6 month (Type: ACTIVE_COMPARATOR): Administration of 3rd dose at 6 months quadrivalent human papillomavirus vaccine

Based on this trial design, predict the completion outcome and termination type (if applicable).